Abstract

BackgroundThe optimal delivery route to enhance effectiveness of regenerative therapeutics to the human heart is poorly understood. Direct intra-myocardial (IM) injection is the gold standard, however, it is relatively invasive. We thus compared targeted IM against less invasive, catheter-based intra-coronary (IC) delivery to porcine myocardium for the acute retention of nanoparticles using cardiac magnetic resonance (CMR) imaging and viral vector transduction using qPCR.MethodsFerumoxytol iron oxide (IO) nanoparticles (5 ml) were administered to Yorkshire swine (n = 13) by: (1) IM via thoracotomy, (2) catheter-based IC balloon-occlusion (BO) with infusion into the distal left anterior descending (LAD) coronary artery, (3) IC perforated side-wall (SW) infusion into the LAD, or (4) non-selective IC via left main (LM) coronary artery infusion. Hearts were harvested and imaged using at 3T whole-body MRI scanner. In separate Yorkshire swine (n = 13), an adeno-associated virus (AAV) vector was similarly delivered, tissue harvested 4–6 weeks later, and viral DNA quantified from predefined areas at risk (apical LV/RV) vs. not at risk in a potential mid-LAD infarct model. Results were analyzed using pairwise Student's t-test.ResultsIM delivery yielded the highest IO retention (16.0 ± 4.6% of left ventricular volume). Of the IC approaches, BO showed the highest IO retention (8.7 ± 2.2% vs. SW = 5.5 ± 4.9% and LM = 0%) and yielded consistent uptake in the porcine distal LAD territory, including the apical septum, LV, and RV. IM delivery was limited to the apex and anterior wall, without septal retention. For the AAV delivery, the BO was most efficient in the at risk territory (Risk: BO = 6.0 × 10−9, IM = 1.4 × 10−9, LM = 3.2 × 10−10 viral copies per μg genomic DNA) while all delivery routes were comparable in the non-risk territory (BO = 1.7 × 10−9, IM = 8.9 × 10−10, LM = 1.2 × 10−9).ConclusionsDirect IM injection has the highest local retention, while IC delivery with balloon occlusion and distal infusion is the most effective IC delivery technique to target therapeutics to a heart territory most in risk from an infarct.

Highlights

  • Cardiac gene and stem cell therapies present promising avenues to stimulate myocardial recovery after an infarct or from nonischemic cardiomyopathies [1,2,3]

  • Trans-epicardial IM techniques are limited by the invasiveness of the approach to reach the heart, while the IC options may be limited by impermeability of the vascular endothelium and rapid washout of the therapeutic [6]

  • We favored troponin I based on previous studies of biomarkers of myocardial ischemia in porcine models [15] and chose not to perform creatinine kinase (CK-MB) assessment due to possible confounding results from intercostal muscle injury induced by the thoracotomy performed for IM injection

Read more

Summary

Introduction

Cardiac gene and stem cell therapies present promising avenues to stimulate myocardial recovery after an infarct or from nonischemic cardiomyopathies [1,2,3]. Intra-myocardial (IM) injection involves direct epicardial or catheter-based trans-endocardial delivery of the therapeutic into the interstitial space of the heart wall [7]. Pericardial dwelling has been used to facilitate slow uptake of the therapeutic to the epicardium [13] Among these delivery strategies, trans-epicardial IM techniques are limited by the invasiveness of the approach to reach the heart (most commonly thoracotomy), while the IC options may be limited by impermeability of the vascular endothelium and rapid washout of the therapeutic [6]. We compared targeted IM against less invasive, catheter-based intra-coronary (IC) delivery to porcine myocardium for the acute retention of nanoparticles using cardiac magnetic resonance (CMR) imaging and viral vector transduction using qPCR

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call